Phase I trial of XOMA 358 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2016
Price : $35 *
At a glance
- Drugs RZ 358 (Primary)
- Indications Hyperinsulinaemia; Hypoglycaemia; Insulinoma
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors XOMA
- 15 Sep 2016 According to XOMA media release, updates from this and other three studies of XOMA-358 were presented in a webcast on 15 Sep 2016.
- 11 Mar 2015 Status changed from recruiting to completed, according to a XOMA Corporation media release.
- 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.